Mizuho Markets Americas’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,200
Closed -$2.82M 198
2024
Q2
$2.82M Buy
+5,200
New +$2.75M 0.07% 156
2023
Q4
Sell
-14,715
Closed -$6.41M 181
2023
Q3
$6.41M Buy
+14,715
New +$6.67M 0.22% 62

Other funds holding ELV

Mizuho Markets Americas's ELV Position: Q3 2024 in Review

Mizuho Markets Americas sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 5,200 shares — an estimated $2.82M sold.

Mizuho Markets Americas first reported a position in ELV in Q3 2023 and held it in 2 quarters. The position peaked at $6.41M in Q3 2023. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Mizuho Markets Americas reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Mizuho Markets Americas sold 5,200 Elevance Health shares in Q3 2024, an estimated $2.82M.
  • Mizuho Markets Americas first reported a position in Elevance Health in Q3 2023 and held it in 2 quarters.
  • Mizuho Markets Americas's Elevance Health position peaked at $6.41M in Q3 2023.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Mizuho Markets Americas's 13F filing for Q3 2024, filed 6 Nov 2024.